Kåre Schultz
2018
Compensation breakdown
Bonus | $20,000,000 |
---|---|
Non-Equity Incentive Plan | $3,790,360 |
Option Awards | $1,500,019 |
Salary | $2,000,000 |
Stock Awards | $4,499,977 |
Other | $679,519 |
Total | $32,469,875 |
Schultz received $20M in bonus, accounting for 62% of the total pay in 2018.
Schultz also received $3.8M in non-equity incentive plan, $1.5M in option awards, $2M in salary, $4.5M in stock awards and $679.5K in other compensation.
Rankings
In 2018, Kåre Schultz's compensation ranked 58th out of 14,244 executives tracked by ExecPay. In other words, Schultz earned more than 99.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 58 | 100th |
Manufacturing | 13 | 100th |
Chemicals And Allied Products | 4 | 100th |
Drugs | 2 | 100th |
Pharmaceutical Preparations | 1 | 100th |
Schultz's colleagues
We found four more compensation records of executives who worked with Kåre Schultz at Teva Pharmaceutical Industries in 2018.
2018
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2018
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2018
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2018
Michael McClellan
Teva Pharmaceutical Industries
Chief Financial Officer
News
April 13, 2022
April 21, 2021
April 22, 2020
April 16, 2019